 LONDON and NEW YORK, July 02, 2021 GLOBE NEWSWIRE -- Tiziana Life Sciences plc Nasdaq: TLSA AIM: TILS Tiziana or the Company, a biotechnology company focused on innovative therapeutics for oncology, inflammation and infectious diseases, today announces that the Forms 20-F and F-6 filed by Accustem Sciences Limited with the SEC have been declared effective, enabling the completion of the in specie distribution and spin out of Accustem Sciences Limited. These documents together can be found at 